Expanding newborn screening: process, policy, and priorities.
In the 1960s, newborn screening programs tested for a single very rare but serious disorder. In recent years, thanks to the development of new screening technology, they have expanded into panels of tests; a federally sponsored expert group has recommended that states test for twenty-nine core disorders and twenty-five secondary disorders. By the standards used to decide whether to introduce new preventive health services into clinical use, the decision-making in newborn screening policy has been lax.
Moyer
Virginia A
VA
Baylor College of Medicine and Texas Children's Hospital, USA.
Calonge
Ned
N
Teutsch
Steven M
SM
Botkin
Jeffrey R
JR
D042964:Acyl-CoA Dehydrogenase / Q000172:deficiency; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000235:genetics; D005826:Genetics, Medical; D006292:Health Priorities; D006801:Humans; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors / Q000175:diagnosis; D015997:Neonatal Screening / Q000379:methods / Q000458:organization & administration / Q000592:standards / Q000639:trends; D010661:Phenylketonurias / Q000175:diagnosis; D012955:Societies, Medical; D053719:Tandem Mass Spectrometry; D014481:United States
D042964:Acyl-CoA Dehydrogenase